
Stocks Drop In Major Reversal… And Opportunities In A Red-Hot Biotech Sector 11/20/25
CNBC's "Fast Money"
00:00
Biotech Rally Driven by M&A and Science
John Flavin explains why M&A, strong science, and state funding are reviving biotech valuations and venture returns.
Play episode from 31:52
Transcript


